Skip to the page

Data / FDA device clearances / Medical Genetics

FDA Medical Genetics device clearances: 41 since Nov 2024

The full list. FDA medical genetics device clearances and approvals: 41 rows for $5, FDA 510(k) and PMA decisions dated November 11, 2024 to October 30, 2026. The list gains about 3 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (pathway, device name, applicant address, contact, date received, device type and 6 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery.

For agents and scripts: this list is ordered at https://specstream.ai/data/fda-clearances/panel/medical-genetics, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated October 27, 2026. Source: openFDA device 510(k) and PMA (U.S. Food and Drug Administration).

FDA made 41 device decisions in medical genetics (FDA review panel) from December 6, 2024 to October 27, 2026: 1 510(k) clearances and De Novo grants and 40 PMA approvals and supplements, for 10 applicants. The newest, P250029/S003 on October 27, 2026, is SimpleScreen™ CRC from Freenome, LLC.

The request: Every new FDA clearance or approval of a medical genetics device, with the applicant, its address and the product code. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every new FDA device clearance and approval as openFDA publishes it, and this page is that reading. Ask for the specialties, product codes or states you follow and each new decision arrives in your sheet, CRM, Slack or agent with the applicant and its address.

  • 41Decisions
  • 1510(k) and De Novo
  • 40PMA
  • October 27, 2026Latest decision

Newest decisions

The newest 41 of 41, each linked to its FDA record. The full list adds the applicant's address, the 510(k) contact as FDA prints it, the device class and the date received.

Decision dateNumberDeviceApplicantLocationDecisionTypeProduct codeSource
October 27, 2026P250029/S003SimpleScreen™ CRCFreenome, LLCCalifornia30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
October 16, 2026P240010/S007MI Cancer SeekCaris Life SciencesArizonaApprovedPMA real-time process supplementPQPaccessdata.fda.gov
October 5, 2026P230009/S021ShieldGuardant Health, Inc.California30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
September 16, 2026P230009/S020ShieldGuardant Health, Inc.California30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
September 15, 2026P250046OncoMate® MSI Dx Analysis SystemPromega CorporationWisconsinApprovedPMA original approvalSFLaccessdata.fda.gov
August 26, 2026P250029/S001SimpleScreen™ CRCFreenome, LLCCalifornia30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
July 30, 2026P250036PGDx elio tissue complete CDxPersonal Genome Diagnostics, Inc.MarylandApprovedPMA original approvalPQPaccessdata.fda.gov
July 24, 2026P250029SimpleScreen™ CRCFreenome, LLCCaliforniaApprovedPMA original approvalPHPaccessdata.fda.gov
July 22, 2026P230009/S010ShieldGuardant Health, Inc.CaliforniaApprovedPMA 180-day supplementPHPaccessdata.fda.gov
July 21, 2026P230009/S018ShieldGuardant Health, Inc.California30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
July 2, 2026P240010/S010MI Cancer SeekCaris Life SciencesArizona30-day notice acceptedPMA 30-day noticePQPaccessdata.fda.gov
July 2, 2026K252243Fastplex™ BCR-ABL (p210) %IS digital PCR KitSuzhou Precigenome, Ltd. Co;ChinaSubstantially Equivalent510(k) traditionalOYXaccessdata.fda.gov
May 28, 2026P240010/S009MI Cancer Seek®Caris Life SciencesArizona30-day notice acceptedPMA 30-day noticePQPaccessdata.fda.gov
May 28, 2026P170041/S009Abbott RealTime IDH1Abbott Molecular, Inc.Illinois30-day notice acceptedPMA 30-day noticeOWDaccessdata.fda.gov
May 28, 2026P170005/S006Abbott RealTime IDH2Abbott Molecular, Inc.Illinois30-day notice acceptedPMA 30-day noticeOWDaccessdata.fda.gov
May 21, 2026P230009/S016ShieldGuardant Health, Inc.California30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
May 6, 2026P180043/S010QIAGEN therascreen® FGFR RGQ RT-PCR KitQIAGEN GmbHApprovedPMA real-time process supplementOWDaccessdata.fda.gov
April 15, 2026P230009/S014ShieldGuardant Health, Inc.CaliforniaApprovedPMA real-time process supplementPHPaccessdata.fda.gov
April 1, 2026P230009/S015ShieldGuardant Health, Inc.California30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
March 20, 2026P170041/S008Abbott RealTime IDH1Abbott Molecular, Inc.Illinois30-day notice acceptedPMA 30-day noticeOWDaccessdata.fda.gov
March 20, 2026P170005/S005Abbott RealTime IDH2Abbott Molecular, Inc.Illinois30-day notice acceptedPMA 30-day noticeOWDaccessdata.fda.gov
February 4, 2026P230009/S013ShieldGuardant Health, Inc.California30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
December 22, 2025P230009/S011ShieldGuardant Health, Inc.California30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
November 5, 2025P240026OncoMate® MSI Dx Analysis SystemPromega CorporationWisconsinApprovedPMA original approvalSFLaccessdata.fda.gov
October 30, 2025P230009/S009ShieldGuardant Health, Inc.California30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
October 22, 2025P190001/S002therascreen® PIK3CA RGQ PCR KitQIAGEN GmbHApprovedPMA 180-day supplementOWDaccessdata.fda.gov
October 3, 2025P180043/S007QIAGEN therascreen® FGFR RGQ RT-PCR KitQIAGEN GmbHApprovedPMA 180-day supplementOWDaccessdata.fda.gov
September 23, 2025P230009/S008ShieldGuardant Health, Inc.California30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
August 15, 2025P250005Idylla CDx MSI TestBiocartis Us, Inc.IllinoisApprovedPMA original approvalSFLaccessdata.fda.gov
July 23, 2025P230009/S007ShieldGuardant Health, Inc.California30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
June 20, 2025P220006/S007VENTANA FOLR1 (FOLR-2.1) RxDx AssayVentana Medical Systems, Inc.Arizona30-day notice acceptedPMA 30-day noticeQULaccessdata.fda.gov
June 18, 2025P240010/S005MI Cancer SeekCaris Life SciencesArizona30-day notice acceptedPMA 30-day noticePQPaccessdata.fda.gov
June 9, 2025P240010/S004MI Cancer SeekCaris Life SciencesArizona30-day notice acceptedPMA 30-day noticePQPaccessdata.fda.gov
June 4, 2025P240010/S003MI Cancer SeekCaris Life SciencesArizonaApprovedPMA real-time process supplementPQPaccessdata.fda.gov
April 28, 2025P230009/S006ShieldGuardant Health, Inc.California30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
March 12, 2025P230009/S005ShieldGuardant Health, Inc.California30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
February 6, 2025P240010/S001MI Cancer SeekCaris Life SciencesArizonaApprovedPMA real-time process supplementPQPaccessdata.fda.gov
January 8, 2025P220006/S006VENTANA FOLR1 (FOLR1-2.1) RxDx AssayVentana Medical Systems, Inc.ArizonaApprovedPMA real-time process supplementQULaccessdata.fda.gov
January 7, 2025P240010/S002MI Cancer SeekCaris Life SciencesArizona30-day notice acceptedPMA 30-day noticePQPaccessdata.fda.gov
January 2, 2025P230009/S004ShieldGuardant Health, Inc.California30-day notice acceptedPMA 30-day noticePHPaccessdata.fda.gov
December 6, 2024P180043/S008therascreen FGFR RGQ PCR KitQIAGEN GmbHApprovedPMA 180-day supplementOWDaccessdata.fda.gov

Applicants with the most decisions

ApplicantDecisionsLatest
Guardant Health, Inc.15October 5, 2026
Caris Life Sciences8October 16, 2026
Abbott Molecular, Inc.4May 28, 2026
QIAGEN GmbH4May 6, 2026
Freenome, LLC3October 27, 2026
Promega Corporation2September 15, 2026
Ventana Medical Systems, Inc.2June 20, 2025
Personal Genome Diagnostics, Inc.1July 30, 2026
Suzhou Precigenome, Ltd. Co;1July 2, 2026
Biocartis Us, Inc.1August 15, 2025

By decision type

Decision typeDecisionsLatest
PMA 30-day notice25October 27, 2026
PMA real-time process supplement6October 16, 2026
PMA original approval5September 15, 2026
PMA 180-day supplement4July 22, 2026
510(k) traditional1July 2, 2026

By state or country

State or countryDecisionsLatest
California18October 27, 2026
Arizona10October 16, 2026
Illinois5May 28, 2026
Wisconsin2September 15, 2026
Maryland1July 30, 2026
China1July 2, 2026

Where FDA publishes these decisions

CC0 1.0 (openFDA). Decisions are as FDA publishes them in its 510(k) and PMA databases, read through openFDA. A PMA row is the original approval or one supplement. The panel is the FDA advisory committee that reviewed the device. FDA adds decisions to openFDA some weeks after their date, so the newest weeks fill in later. The 510(k) contact is in the full list only, as FDA prints it for the submission. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.